How does GWEST's PS Ratio compare to its peers?

GWEST is expensive based on its Price-To-Sales Ratio (1.6x) compared to the peer average (0.9x).

How does GWEST's PS Ratio compare vs other companies in the South American Healthcare Industry?

GWEST is expensive based on its Price-To-Sales Ratio (1.6x) compared to the South American Healthcare industry average (0.8x).

What is GWEST's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate GWEST's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of GWEST when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

GWEST (JMD0.99) is trading below our estimate of [[fair value]] (JMD4.73)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

GWest (JMSE:GWEST) - Stock Price, News & Analysis

GWEST Stock Overview

Engages in the development of commercial properties and provision of healthcare services in Jamaica. More details

GWEST fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 79.1% below our estimate of its fair value

Earnings have grown 41.2% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (JMD480M)

Shares are highly illiquid

Does not have meaningful revenue (JMD302M)

GWest Corporation Limited Competitors

Medical Disposables & Supplies

JMSE:MDS

JA$447.4m

Elite Diagnostic

JMSE:ELITE

JA$639.7m

R.A. Williams Distributors

JMSE:RAWILL

JA$1.7b

Image Plus Consultants

JMSE:IPCL

JA$1.9b

Price History & Performance

Summary of all time highs, changes and price drops for GWest
Historical stock prices
Current Share Price	JA$0.99
52 Week High	JA$1.28
52 Week Low	JA$0.80
Beta	0.0078
11 Month Change	0%
3 Month Change	12.50%
1 Year Change	-1.98%
33 Year Change	-1.98%
5 Year Change	5.32%
Change since IPO	-67.00%

Recent updates

Shareholder Returns

	GWEST	JM Healthcare	JM Market
7D	0%	-1.1%	1.3%
1Y	-2.0%	-2.7%	5.7%

Return vs Industry: GWEST matched the JM Healthcare industry which returned -2.7% over the past year.

Return vs Market: GWEST underperformed the JM Market which returned 5.7% over the past year.

Price Volatility

Is GWEST's price volatile compared to industry and market?
GWEST volatility
GWEST Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.0%
Market Average Movement	8.0%
10% most volatile stocks in JM Market	16.4%
10% least volatile stocks in JM Market	4.4%

Stable Share Price: GWEST's share price has been volatile over the past 3 months compared to the JM market.

Volatility Over Time: Insufficient data to determine GWEST's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Wayne Gentles	www.gwestcentre.com

GWest Corporation Limited engages in the development of commercial properties and provision of healthcare services in Jamaica. The company operates medical facilities, which provide urgent care, heart, renal dialysis, facial and oral surgery, radiology, MRI, general dentistry, laboratory, pharmacy, Ob-Gyn, orthopedic surgery, urology, general practitioners, and pediatric services. It also leases and maintains units in GWEST Centre.

GWest Corporation Limited Fundamentals Summary

How do GWest's earnings and revenue compare to its market cap?
GWEST fundamental statistics
Market cap	JA$480.00m
Earnings (TTM)	-JA$3.90m
Revenue (TTM)	JA$302.27m

1.6x

P/S Ratio

-123.1x

P/E Ratio

Is GWEST overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GWEST income statement (TTM)
Revenue	JA$302.27m
Cost of Revenue	JA$213.64m
Gross Profit	JA$88.63m
Other Expenses	JA$92.53m
Earnings	-JA$3.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.008
Gross Margin	29.32%
Net Profit Margin	-1.29%
Debt/Equity Ratio	86.7%

How did GWEST perform over the long term?

See historical performance and comparison

GWEST Stock Overview

Rewards

Risk Analysis

GWest Corporation Limited Competitors

JMSE:MDS

JA$447.4m

JMSE:ELITE

JA$639.7m

JMSE:RAWILL

JA$1.7b

JMSE:IPCL

JA$1.9b

Price History & Performance

Recent News & Updates

New minor risk - Share price stability

First quarter 2025 earnings released: JA$0.032 loss per share (vs JA$0.025 loss in 1Q 2024)

Full year 2024 earnings released: JA$0.03 loss per share (vs JA$0.004 profit in FY 2023)

Third quarter 2024 earnings released: EPS: JA$0.006 (vs JA$0.014 loss in 3Q 2023)

Second quarter 2024 earnings released: JA$0.035 loss per share (vs JA$0.018 loss in 2Q 2023)

Full year 2023 earnings released: EPS: JA$0.004 (vs JA$0.05 in FY 2022)

Recent updates

New minor risk - Share price stability

First quarter 2025 earnings released: JA$0.032 loss per share (vs JA$0.025 loss in 1Q 2024)

Full year 2024 earnings released: JA$0.03 loss per share (vs JA$0.004 profit in FY 2023)

Third quarter 2024 earnings released: EPS: JA$0.006 (vs JA$0.014 loss in 3Q 2023)

Second quarter 2024 earnings released: JA$0.035 loss per share (vs JA$0.018 loss in 2Q 2023)

Full year 2023 earnings released: EPS: JA$0.004 (vs JA$0.05 in FY 2022)

Investor sentiment improves as stock rises 27%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: JA$0.014 loss per share (vs JA$0.023 loss in 3Q 2022)

Investor sentiment improved over the past week

Second quarter 2023 earnings released: JA$0.018 loss per share (vs JA$0.015 loss in 2Q 2022)

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Full year 2022 earnings released

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: JA$0.015 loss per share (vs JA$0.042 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS JA$0.046 (vs JA$0.098 loss in FY 2020)

New 90-day high: JA$0.80

Third quarter 2021 earnings released: JA$0.03 loss per share (vs JA$0.043 loss in 3Q 2020)

Konrad Kirlew Demits the Office of CEO of GWest Corporation Limited

Second quarter 2021 earnings released: JA$0.04 loss per share

New 90-day low - JA$0.56

First quarter earnings released

New 90-day low - JA$0.70

Shareholder Returns

Price Volatility

About the Company

GWest Corporation Limited Fundamentals Summary

1.6x

-123.1x

Earnings & Revenue